• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Teva, MedinCell win FDA approval for slow-release schizophrenia drug Uzedy

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 01, 2023 at 10:13: PM
via After 20 years developing technology for slow-release injectable drugs, MedinCell of France has won its first FDA approval.

In combination with Teva, MedinCell has scored an FDA nod for Uzedy (risperidone), an extended-release injectable suspension treatment for adults with schizophrenia.

article source
 




Top Bottom
Back
Quote